Newsletter Archive >> Fall 2011 >> Eurofins MI facility integrates with Lancaster Labs

Eurofins MI facility integrates with Lancaster Labs

Sidebar Image

As part of Eurofins’ acquisition of Lancaster Laboratories, its AvTech site in Portage, MI, is transitioning under the Lancaster Labs’ operations umbrella and will be known as Lancaster Laboratories in 2012. This pharmaceutical testing facility consists of two buildings, totaling 40,000 square feet and currently includes approximately 29,000 square feet of laboratory space with planned space for increased capacity and future growth. In addition, the facility is located on 29 acres, which provides added potential for expansion as the business grows.

The Michigan site specializes in small molecule product testing, animal health testing, including antibiotic analyses, QC release testing, stability storage, water testing, environmental monitoring testing, microbial limits and anti-microbial effectiveness testing, as well as method development and validation of chromatographic methods. With plans to add on-site sampling services within the region, the facility has the capacity to customize services for clients seeking larger partnerships in outsourcing solutions.

Lancaster Laboratories has always operated under an independent quality system, successfully meeting cGMP expectations during both client and regulatory audits. However, in an effort to focus on continuous improvement, position for growth and provide centralized support, plans have been established to harmonize quality and operational systems with those at Lancaster Laboratories in Pennsylvania. The integration of high level corporate quality policies and practices is already underway with full harmonization expected late in 2012. LIMS and other IT systems are also being integrated. While there will still be site-specific differences and local procedures based on services, size and facilities, the overall goal will be to provide a seamless and unified approach for systems, support and data quality regardless of location.

For more specific information, contact Bio/Pharma Business Development at 717-656-2300.